Are you Dr. Peerani?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Office
1 Gustave L Levy Pl
New York, NY 10029Phone+1 212-659-9697Fax+1 212-849-2574
Clinical Trials
- Assessing the Effectiveness of a Stress Reduction Intervention in Inflammatory Bowel Disease (IBD) Start of enrollment: 2019 Feb 22
Publications & Presentations
PubMed
- 88 citationsDevelopment and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s DiseaseParambir S. Dulai, Brigid S. Boland, Siddharth Singh, Khadija Chaudrey, Jenna L. Koliani-Pace
Gastroenterology. 2018-09-01 - 85 citationsInflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific FeaturesCarolina Palmela, Farhad Peerani, Daniel Castaneda, Joana Torres, Steven H. Itzkowitz
Gut and Liver. 2018-01-15 - 234 citationsThe Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY ConsortiumParambir S. Dulai, Siddharth Singh, Xiaoqian Jiang, Farhad Peerani, Neeraj Narula
The American Journal of Gastroenterology. 2016-08-01
